Zealthy Semaglutide Review 2026

Almost every provider in this category treats insurance as somebody else's problem and routes you to compounded medication. Zealthy inverts that, and it is the most interesting thing about it.

Zealthy operates an insurance coordination team that submits prior authorisations for branded GLP-1s — Ozempic, Wegovy, Zepbound and Mounjaro — and advertises a resulting cost as low as $25 a month against a retail reference it cites at $1,349.

That is a genuine service. Prior authorisation is the main barrier between an insured patient and a covered GLP-1, and it is tedious, technical work most people abandon. Someone doing it on your behalf has real value that a $99 compounded plan does not replicate.

But the $25 is not a price

If coverage does not come through, the published self-pay fallback is compounded semaglutide as low as $151 a month — and that figure itself carries a condition, applying when purchased quarterly. Against CoreAge Rx at $79 with no membership and Mochi at $139 all-in, $151 on a three-month prepayment is unremarkable.

What Zealthy does not publish

More than any other provider in this set. Its membership price is not published on the pages we reviewed. Neither is its cancellation process, refund policy, eligibility criteria, lab requirements or pharmacy partners. Its FAQ lists all of these as topics, but the answers sit behind collapsed accordions that do not render in readable form.

For a company whose value proposition is navigating opacity on your behalf, being this opaque about its own terms is an awkward look. Get the membership cost and the cancellation terms in writing before you sign up.

Its compounded offering also covers semaglutide only. There is no published compounded tirzepatide rate, so if you want that molecule without insurance, Zealthy is not the provider for it.

What compounded semaglutide actually is

Semaglutide is the active ingredient in Ozempic and Wegovy, both FDA-approved products from Novo Nordisk. A compounded version is prepared by a pharmacy rather than manufactured by Novo Nordisk, and it is not an FDA-approved product. FDA has not evaluated it for safety, effectiveness or quality.

That distinction is the single most important thing to understand before buying. The efficacy data you have read about — the 15% average body-weight reduction, the cardiovascular outcomes — comes from trials of the branded product. Those results are routinely used to sell compounded versions that were never in the trials.

Dosing typically starts at 0.25 mg weekly and escalates over several months toward a maintenance dose, which is why dose-dependent pricing matters so much: a plan that looks cheap at the starting dose can cost several times more by the time you reach a therapeutic one.

The common side effects are gastrointestinal — nausea, vomiting, diarrhoea, constipation — and are usually worst in the days after a dose increase. They are the main reason people stop. Slower titration and adequate fibre and fluid intake are the standard mitigations.

Before you buy from anyone

1. Get the total monthly cost in writing — medication plus any membership, not the headline figure.
2. Ask whether the price changes as your dose increases. This is where most of the money is lost.
3. Ask which pharmacy compounds it, and whether it is a 503A or 503B facility.
4. Confirm what happens if you stop after one month, and whether there is an auto-rebill.
5. Ask whether a refund is available if a provider declines to prescribe.
6. Tell the prescriber every medication and supplement you take, including anything bought online.